Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

The Antidiabetic Drug Liraglutide Minimizes the Non-Cholinergic Neurotoxicity of the Pesticide Mipafox in SH-SY5Y Cells

Full text
Author(s):
Fernandes, Lais Silva [1] ; dos Santos, Neife Aparecida G. [1] ; Emerick, Guilherme Luz [2] ; dos Santos, Antonio Cardozo [1]
Total Authors: 4
Affiliation:
[1] Univ Sao Paulo, FCFRP, Dept Anal Clin Toxicol & Bromatol, Ave Cafe S-N, BR-14040903 Ribeirao Preto, SP - Brazil
[2] Univ Fed Mato Grosso ICS UFMT CUS, Inst Ciencias Saude, Sinop, MT - Brazil
Total Affiliations: 2
Document type: Journal article
Source: NEUROTOXICITY RESEARCH; v. 35, n. 1, p. 150-159, JAN 2019.
Web of Science Citations: 4
Abstract

Organophosphorus (OPs) compounds have been widely used in agriculture, industry, and household, and the neurotoxicity induced by them is still a cause of concern. The main toxic mechanism of OPs is the inhibition of acetylcholinesterase (AChE); however, the delayed neuropathy induced by OPs (OPIDN) is mediated by other mechanisms such as the irreversible inhibition of 70% of NTE activity (neuropathy target esterase) that leads to axonal degeneration. Liraglutide is a long-lasting GLP-1 analog clinically used as antidiabetic. Its neurotrophic and neuroprotective effects have been demonstrated in vitro and in experimental models of neurodegenerative diseases. As in OPIDN, axonal degeneration also plays a role in neurodegenerative diseases. Therefore, this study investigated the protective potential of liraglutide against the neurotoxicity of OPs by using mipafox as a neuropathic agent (at a concentration able to inhibit and age 70% of NTE activity) and a neuronal model with SH-SY5Y neuroblastoma cells, which express both esterases. Liraglutide protected cells against the neurotoxicity of mipafox by increasing neuritogenesis, the uptake of glucose, the levels of cytoskeleton proteins, and synaptic-plasticity modulators, besides decreasing the pro-inflammatory cytokine interleukin 1 and caspase-3 activity. This is the first study to suggest that liraglutide might induce beneficial effects against the delayed, non-cholinergic neurotoxicity of OPs. (AU)

FAPESP's process: 12/16319-3 - In vitro study of the mechanisms of neurotoxicity of the organophosphate trichlorfon: strategies for neuroprotection
Grantee:Lais da Silva Fernandes
Support Opportunities: Scholarships in Brazil - Master
FAPESP's process: 12/00168-6 - Organophosphate-induced delayed neuropathy: in vitro studies of mechanisms of neurotoxicity and neuroprotection
Grantee:Guilherme Luz Emerick
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 13/26906-6 - Organophosphorus-induced delayed neuropathy: in vitro study of the mechanisms of neurotoxicity of trichlorfon and strategies of neuroprotection
Grantee:Antonio Cardozo dos Santos
Support Opportunities: Regular Research Grants